NIH-funded research R01 grant

How abnormal particles from human islets affect type 1 diabetes progression

Official title: Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression

Funded at Weill Medical Coll of Cornell Univ · NIH-10911368 · Data updated 2026-11-12

This study is looking at tiny particles released by insulin-producing cells in the pancreas to see how they might affect the progression of type 1 diabetes, with the hope of finding new ways to help manage the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 21, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$678,579
NIH project number5R01DK137517-02
Project IDNIH-10911368 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with type 1 diabetes, as well as those at risk of developing the condition.

Less likely to help

Patients with type 2 diabetes or other forms of diabetes unrelated to the mechanisms being studied may not benefit from this research.

What this research studies

This research investigates the role of abnormal extracellular vesicles and particles (EVPs) secreted by human islets in the progression of type 1 diabetes (T1D). By analyzing these EVPs, the research aims to understand how they impact the function and survival of insulin-producing beta cells and their interaction with immune cells. The study utilizes human samples, including islets from healthy and T1D donors, to identify specific proteins associated with these EVPs. This approach seeks to provide insights into the mechanisms driving T1D and potentially identify new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating type 1 diabetes by targeting the mechanisms involved in beta cell dysfunction.

How similar studies have gone: While some studies have explored EVPs in mouse models, this research is novel as it focuses specifically on human samples and their implications for T1D progression.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Chen, Shuibing — Weill Medical Coll of Cornell Univ
  • Study coordinator: Chen, Shuibing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.